Depletion of NSUN2 results in decreased growth of human squamous-cell-carcinoma xenografts, suggesting that NSUN2 could be potentially targeted for cancer therapy (Frye and Watt 2006). Here, NSUN2 is linked to squamous cell carcinoma.